Stay updated on Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.

Latest updates to the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page
- Check4 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, replacing the expected study details with an error screen. The change effectively removes the visible content and navigation for this study on that page.SummaryDifference20%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe revision label at the bottom of the page updated from v3.6.5 to v3.6.6, signaling a new site version.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page now includes a direct link to obtain contact information for nearby study centers and expanded metadata/keywords for Hemophilia-related topics and study context, improving navigation and discoverability. An error page claiming the site was unavailable has been removed, restoring access to the study details.SummaryDifference71%

- Check47 days agoChange DetectedThe page footer now displays Revision: v3.6.5, replacing v3.6.4. This reflects a small platform update rather than any changes to the study details or visible content.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page's footer revision label was updated from Revision: v3.6.3 to Revision: v3.6.4. This represents a minor UI update with no apparent changes to study data or content.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 in the page footer. This reflects a minor deployment or template update to the page.SummaryDifference0.0%

Stay in the know with updates to Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.